Preoperative, postoperative and one-year follow-up of N-terminal pro-B-type natriuretic peptide levels in volume overload of aortic regurgitation: Comparison with pressure overload of aortic stenosis

Cardiology

Volumn 116, Issue 4, 2010, Pages 286-291

  Song, Bong Gun ^a   Park, Yong Hwan ^a   Kang, Gu Hyun ^a   Chun, Woo Jung ^a   Oh, Ju Hyeon ^a   Choi, Jin Oh ^a   Lee, Sang Chol ^a   Park, Seung Woo ^a   Oh, Jae K ^a   Sung, Ki Ick ^a   Park, Pyowon ^a   Jeon, Eun Seok ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Aortic valve disease; Left ventricular mass index; N terminal pro B type natriuretic peptide

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; CHI-SQUARE DISTRIBUTION; COMORBIDITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77956793526     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000318019     Document Type: Article

References (25)

1. de Lemos JA, McGuire DK, Drazner MH: Btype natriuretic peptide in cardiovascular disease. Lancet 2003; 362: 316-322.
2. Dries DL: Relevance of molecular forms of brain natriuretic peptide for natriuretic peptide research. Hypertension 2007; 49: 971-973.
3. Hosoda K, Nakao K, Mukoyama M, Saito Y, Jougasaki M, Shirakami G, Suga S, Ogawa Y, Yasue H, Imura H: Expression of brain natriuretic peptide gene in human heart. Production in the ventricle. Hypertension 1991; 17: 1152-1155.
4. Rubattu S, Sciarretta S, Valenti V, Stanzione R, Volpe M: Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am J Hypertens 2008; 21: 733-741.
5. Ikeda T, Matsuda K, Itoh H, Shirakami G, Miyamoto Y, Yoshimasa T, Nakao K, Ban T: Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis. Am Heart J 1997; 133: 307-314.
6. Kupari M, Turto H, Lommi J, Makijarvi M, Parikka H: Transcardiac gradients of n-terminal B-type natriuretic peptide in aortic valve stenosis. Eur J Heart Fail 2005; 7: 809-814.
7. Weber M, Hausen M, Arnold R, Moellmann H, Nef H, Elsaesser A, Mitrovic V, Hamm C: Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NTproBNP) in patients with chronic aortic regurgitation. Int J Cardiol 2008; 127: 321-327.
8. Choure A, Tang WH, Mills RM: Natriuretic peptides in valvular heart diseases. Heart Fail Clin 2006; 2: 345-352.
9. Orlowska-Baranowska E, Baranowski R, Greszata L, Stepinska J: Brain natriuretic peptide as a marker of left ventricular hypertrophy in patients with aortic stenosis. J Heart Valve Dis 2008; 17: 598-605.
10. Qi W, Mathisen P, Kjekshus J, Simonsen S, Bjornerheim R, Endresen K, Hall C: Natriuretic peptides in patients with aortic stenosis. Am Heart J 2001; 142: 725-732.
11. Krayenbuehl HP, Hess OM, Monrad ES, Schneider J, Mall G, Turina M: Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 1989; 79: 744-755.
12. Qi W, Mathisen P, Kjekshus J, Simonsen S, Endresen K, Bjornerheim R, Hall C: The effect of aortic valve replacement on N-terminal natriuretic propeptides in patients with aortic stenosis. Clin Cardiol 2002; 25: 174-180.
13. Weber M, Arnold R, Rau M, Elsaesser A, Brandt R, Mitrovic V, Hamm C: Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J 2005; 26: 1023-1030.
14. Baumgartner H: Neurohormones in valvular heart disease: what can they tell us? Eur Heart J 2008; 29: 290-292.
15. Walther T, Rastan A, Falk V, Lehmann S, Garbade J, Funkat AK, Mohr FW, Gummert JF: Patient prosthesis mismatch affects shortand long-term outcomes after aortic valve replacement. Eur J Cardiothorac Surg. 2006; 30: 15-19.
16. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ: Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
17. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
18. Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, Manning WJ, Morehead A, Kitzman D, Oh J, Quinones M, Schiller NB, Stein JH, Weissman NJ: American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 2004; 17: 1086-1119.
19. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ: Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16: 777-802.
20. Lund O, Kristensen LH, Baandrup U, Hansen OK, Nielsen TT, Emmertsen K, Jensen FT, Flo C, Rasmussen BS, Pilegaard HK: Myocardial structure as a determinant of pre- and postoperative ventricular function and long-term prognosis after valve replacement for aortic stenosis. Eur Heart J 1998; 19: 1099-1108.
21. Della Corte A, Salerno G, Chiosi E, Iarussi D, Santarpino G, Miraglia M, Naviglio S, De Feo M: Preoperative, postoperative and 1-year follow-up N-terminal pro-B-type natriuretic peptide levels in severe chronic aortic regurgitation: correlations with echocardiographic findings. Interact Cardiovasc Thorac Surg 2008; 7: 419-424; discussion 424.
22. Vanderheyden M, Goethals M, Verstreken S, De Bruyne B, Muller K, Van Schuerbeeck E, Bartunek J: Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. J Am Coll Cardiol 2004; 44: 2349-2354.
23. Neverdal NO, Knudsen CW, Husebye T, Vengen OA, Pepper J, Lie M, Tonnessen T: The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis - one year followup. Eur J Heart Fail 2006; 8: 257-262.
24. Wiese S, Breyer T, Dragu A, Wakili R, Burkard T, Schmidt-Schweda S, Fuchtbauer EM, Dohrmann U, Beyersdorf F, Radicke D, Holubarsch CJ: Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation 2000; 102: 3074-3079.
25. Ogawa Y, Tamura N, Chusho H, Nakao K: Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart. Can J Physiol Pharmacol 2001; 79: 723-729.